Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort Study

GS provided a modest increase in utility after first-tier cancer gene panels, at the cost of a high frequency of uncertain results. Furthermore, most positives were low/moderate cancer risk results that did not have corresponding evidence-based, management guidelines.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2024-12-01
DOI
https://doi.org/10.1200/po-24-00407
Citations
1
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort Study

Craig C. Earle, Jada G. Hamilton, Irfan A. Dhalla, Kasmintan A. Schrader et al.
1 citations
JCO Precision Oncology
BRCA gene mutations in cancer
0.55
article

Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort Study

Craig C. Earle, Jada G. Hamilton, Irfan A. Dhalla, Kasmintan A. Schrader, Kevin E. Thorpe, Yvonne Bombard, Jordan P. Lerner‐Ellis, Nancy N. Baxter, Susan Randall Armel, Tracy Graham, Mark E. Robson, Chantal F. Morel, Wanrudee Isaranuwatchai, Daena Hirjikaka, Timothy Caulfield, Stephen W. Scherer, Salma Shickh, Christine Elser, Michelle Mujoomdar, Abdul Noor, José‐Mario Capo‐Chichi, Raymond H. Kim, Tammy Clifford, Iris Cohn, Andrea Eisen, Marc Clausen, Emily Glogowski, Kenneth Bond, Elena Greenfeld, Melyssa Aronson, Jordan Sam, Seema Panchal, Emma Reble, Monika Kastner, Chloe Mighton, June Carroll, Andreas Laupacis, Kenneth Offit, Terrence Sullivan, Michael F. Evans, Adena Scheer
article en
1 citations

Abstract

GS provided a modest increase in utility after first-tier cancer gene panels, at the cost of a high frequency of uncertain results. Furthermore, most positives were low/moderate cancer risk results that did not have corresponding evidence-based, management guidelines.

JCO Precision OncologyVol. 8(8)
Ontario Institute for Cancer Research (CA), Mount Sinai Hospital (CA), St. Michael's Hospital (CA), Sunnybrook Health Science Centre (CA), University Health Network (CA), University of British Columbia (CA), The University of Melbourne (AU), University of Toronto (CA), Lunenfeld-Tanenbaum Research Institute (CA), Hospital for Sick Children (CA), Health Sciences Centre (CA), Princess Margaret Cancer Centre (CA), Unity Health Toronto
Good health and well-being
Openalex Percentile: Top 24%
BRCA gene mutations in cancer
0.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.